AliveCor introduces the world's first AI that can detect heart attack on a reduced leadset in monumental dual clearance by the FDA. Today, AliveCor launched the all-new, AI-powered Kardia 12L ECG System, which is FDA-cleared to detect 35 cardiac conditions including serious conditions like acute myocardial infarction (MI) and the most common types of cardiac ischemia. The 12-lead ECG has been the standard of cardiac care since 1954, but its availability has been limited. Until now. Small enough to fit in a pocket, Kardia 12L boasts advanced AI algorithms that are substantially equivalent to the current state-of-the-art ECG analysis solutions. Learn how Kardia 12L can assist physicians in rapid disease detection, enhance patient experience, and expand access to accurate heart data faster and more conveniently than ever before. prnewswire.com/news-releases…

AliveCor is at #AAFPFMX in Nashville this week! Our team is excited to meet with family physicians and care teams to showcase our point-of-care cardiac solutions. Plus, check out the Kardia 12L ECG System–a first-of-its-kind, portable and pocket-friendly system powered by the world’s first AI capable of detecting 39 cardiac conditions, including life-threatening heart attacks, using a reduced leadset. We look forward to seeing you at booth #1404.👋 @aafp #AliveCor #ECG #CardiacMonitoring #FamilyMedicine #Healthcare #Kardia12L #MedTech

We’re honored to be named to @TIME's World’s Top HealthTech Companies list for 2026—marking our second consecutive year among the global leaders transforming healthcare.🏆 In a crowded market of heart monitoring solutions, back-to-back recognition from TIME speaks volumes. From advancing personal ECG technology to scaling clinical-grade cardiac AI worldwide, it reinforces why AliveCor continues to lead, innovate, and cut through the noise.🥇 🔗Explore the full ranking on TIME: time.com/article/2026/09/16/… #HealthTech #Innovation #Healthcare #TIME #Awards #DigitalHealth #HealthcareInnovation #Cardiology #CardiacAI

🚨Heart health shouldn’t wait for a crisis. 🚨 Did you know the average wait time to see a cardiologist is 33 days? Meanwhile, conditions like Atrial Fibrillation (AFib) quietly elevate stroke risk by 5x. 𝗧𝗵𝗶𝘀 𝗶𝘀 𝗽𝗿𝗲𝘃𝗲𝗻𝘁𝗮𝗯𝗹𝗲. KardiaComplete helps employees and health plan members take a more proactive approach to heart health. 👉 Heading to HLTH next month? Connect with our team at 𝗯𝗼𝗼𝘁𝗵 #𝟰𝟮𝟯𝟭 to learn how KardiaComplete can help transform virtual cardiovascular care and improve outcomes. 📅 𝗕𝗼𝗼𝗸 𝘁𝗶𝗺𝗲 𝘄𝗶𝘁𝗵 𝘂𝘀: meetings.salesloft.com/alive… @HLTHEVENT #HLTHUSA #HeartHealth #VirtualCare #Cardiology #HealthTech #KardiaComplete

"If you feel like the medical system wasn't built for women, you aren't imagining it." 💔 In a new piece for @katiecouric Media, our CEO, Priya Abani, explains why this diagnostic gap exists, how it puts women’s lives in danger, and what it takes to design technology that actually accounts for women. 🫀🩺 📖 Read Priya's full article: katiecouric.com/health/heart… #WomensHealth #Cardiology #HealthEquity #AliveCor #HeartHealth #HealthTech #DigitalHealth #MedTech

Hello from the 𝗖𝗮𝗻𝗮𝗱𝗶𝗮𝗻 𝗖𝗮𝗿𝗱𝗶𝗼𝘃𝗮𝘀𝗰𝘂𝗹𝗮𝗿 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀 in Ottawa! 👋 The Kardia booth is set up, the team is ready, and our Health Canada-licensed Kardia 12L is here. Stop by to see how our pocket-sized, 12-lead ECG technology is transforming cardiac care workflows. 📍 𝗕𝗼𝗼𝘁𝗵 𝟯𝟮 🗓 𝗢𝗰𝘁𝗼𝗯𝗲𝗿 𝟭𝟱–𝟭𝟳 Meet our team and learn more about how our clinically validated cardiac monitoring solutions can transform care delivery! 🤝 🩺 #CCCongress #Cardiology #Kardia12L #AliveCor #DigitalHealth #MedTech #HeartHealth #HealthCanada

Our Chief Clinical Officer,@BenGreenMD , will be speaking at @medcitynews INVEST Digital Health on October 29 in Dallas, TX. Dr. Green will join industry leaders for the panel “How Are Wearables Changing Health Behavior?” to explore how wearables are evolving from passive tracking to clinically validated data, integrated care, and new opportunities for reimbursement and regulation. 👉Learn more: medcityinvestconference.com/… #DigitalHealth #Wearables #MedTech #CardiacCare #MedCityINVEST #AliveCor #HealthTech #RemotePatientMonitoring

🚨 AliveCor will be at #AAFPFMX in Nashville from October 20-24! 🚨 Visit us at booth #1404 where we'll be showcasing our FDA-cleared Kardia 12L ECG System. Stop by to see how this portable, clinically validated, and pocket-sized solution can transform your ECG diagnostics at the point of care. We look forward to connecting with family physicians and care teams to show how our solutions can boost efficiency and patient comfort. @aafp #AliveCor #ECG #CardiacMonitoring #FamilyMedicine #Healthcare #Kardia12L #MedTech

AliveCor is headed to the 𝗖𝗮𝗻𝗮𝗱𝗶𝗮𝗻 𝗖𝗮𝗿𝗱𝗶𝗼𝘃𝗮𝘀𝗰𝘂𝗹𝗮𝗿 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀 in Ottawa, Canada from October 15–17. In fast-paced cardiovascular care, rapid clinical insights and seamless workflows are vital—and we’re bringing the technology to support both. 🫀 📍 Stop by the 𝗞𝗮𝗿𝗱𝗶𝗮 𝗯𝗼𝗼𝘁𝗵 (#𝟯𝟮) to meet our team and get hands-on with the Kardia 12L ECG System. Lighter than a smartphone and licensed by Health Canada as a medical device, it fits in your pocket and delivers medical-grade clinical depth without the bulk of traditional equipment. Why cardiovascular teams are integrating Kardia 12L: ✅ 𝗣𝗼𝗿𝘁𝗮𝗯𝗶𝗹𝗶𝘁𝘆: Capture a 12-lead ECG anywhere—from busy clinic rooms to bedside rounds. ✅ 𝗘𝗳𝗳𝗶𝗰𝗶𝗲𝗻𝗰𝘆: Reduced leadset and single-cable design for faster data acquisition and streamlined triage. ✅ 𝗩𝗮𝗹𝘂𝗲: Transform care delivery with tech designed to optimize workflow and elevate the patient experience. Check out a live demo of Kardia 12L and learn how our cardiac monitoring solutions can transform care delivery. #CCCongress #Cardiology #Kardia12L #AliveCor #DigitalHealth #MedTech #HeartHealth #HealthCanada

🫀Join us at @heartrhythmcong for an insightful session on Revolutionizing the Standard of Care: AI-Driven 12-Lead ECG Acquisition via the Kardia 12L System. Dr. Yassir Javaid, GP Specialist in Cardiology, will discuss how AI innovation is transforming cardiac care and streamlining 12-lead ECG acquisition. See you in Birmingham! #HRC2026 #Kardia12L #AliveCor #Cardiology #DigitalHealth #MedTech #AIinHealthcare

AliveCor BioPharma will be at the Clinical Trial Innovation Summit at the Genentech campus in South San Francisco on Tuesday, October 13th. Frank Padron, General Manager, BioPharma, will join Sebastian Jayaraj (@bmsnews) and John Rootenberg, MD (@genentech) for a panel moderated by Rajesh Ghosh (@Genentech) on how connected digital health devices are transforming safety monitoring—from periodic snapshots to continuous insight. The discussion will explore how this shift can strengthen data quality and help de-risk clinical development. Also, visit the AliveCor booth to learn more about our clinical-grade, flexible ECG solutions for clinical trials. @PanAgoraPharma #CTIS2026 #ClinicalTrials #DigitalHealth #BioPharma #CardiacSafety #MedTech #AliveCor

How do you scale a digital health category from its earliest days into the future of proactive cardiovascular care?💡🫀 In the latest episode of the 𝗠𝗲𝗱𝗖𝗶𝘁𝘆 𝗣𝗶𝘃𝗼𝘁 𝗣𝗼𝗱𝗰𝗮𝘀𝘁, AliveCor CEO, Priya Abani, sat down with @medcitynews Editor-in-Chief, Arundhati Parmar, to reflect on AliveCor’s journey. Together, they discuss the evolution of personal ECG technology, the resilience required to navigate complex healthtech landscapes, and where digital health and AI-driven care are headed next. 🎙️ Listen to the full conversation to hear Priya’s perspective on leading through growth and shaping the future of cardiology: medcitynews.com/2026/09/medc… #AliveCor #MedCityPivot #DigitalHealth #MedTech #Leadership #Cardiology #HealthTech

🚀 AliveCor is exhibiting at the WELL Health Diagnostic Centres CME Event on Saturday, September 26th. Kick off your morning with us: ⏰ 9:00 AM | Special remarks by Dr. Ben Green, Chief Clinical Officer at AliveCor. After the presentation, visit our exhibit table to: ✅ Experience live demonstrations of our AI-driven ECG technology. ✅ Explore how remote cardiac monitoring integrates into diagnostic practice. ✅ Connect directly with our clinical and product teams. Are you attending? Drop a comment below or stop by our booth. 🔗 Agenda details: welldiagnostics.ca/cme/ #Cardiology #DigitalHealth #AliveCor #HealthTech #RemotePatientMonitoring #MedEd

We are proud to support the #kumpelherz initiative at the upcoming @s04_en home game on September 20th! 💙⚽ Our goal? Perform over 4,000 ECG screenings right at the stadium using KardiaMobile 6L technology and smartwatch data. In just 30 seconds, fans can take a medical-grade ECG—bringing atrial fibrillation (AFib) detection directly to the football community where it matters most. Together, we’re putting heart health at the center of game day. 🫀⚡ 📰 Read more about the campaign covered by WDR: www1.wdr.de/nrw/ruhrgebiet/g… #kumpelherz #vorhofflimmern #bundesliga #ecg #prevention #AliveCor #KardiaMobile #DigitalHealth #StrokePrevention #Cardiology

Conduction system pacing (CSP) offers the promise of true physiologic activation—yet reliably confirming capture and optimizing programming remains one of the field’s most pressing challenges. 💡🫀 Join us at HRX 2026 for an elite roundtable discussion powered by AliveCor: 📌 Advances in Optimizing Conduction System Pacing 📅 Date: Saturday, September 19, 2026 ⏰ Time: 8:50 AM – 9:35 AM EDT 📍 Location: Roundtable 3 Moderated by Dr. Eugene Chung (Massachusetts General Hospital / Harvard Medical School), this session features an outstanding panel of key opinion leaders debating procedural success, signal verification, and how advanced tools can drive durable clinical benefits for patients: • Dr. Neal Bhatia (Emory) • Dr. Mikhael El-Chami (Emory) • Dr. Daniel Frisch (Thomas Jefferson University) • Dr. Nino Isakadze (Johns Hopkins) • Dr. Ajay Pillai (VCU Health) • Dr. Alan Sugrue (Mayo Clinic) • Dr. Pugazhendhi Vijayaraman (Geisinger Heart & Vascular Institute) 👉 Don't miss this high-impact discussion on the future of EP innovation: experiencehrx.com/event/adva… #HRX2026 #HeartRhythm #Electrophysiology #AliveCor #ConductionSystemPacing #Cardiology #MedTech

Introducing KardiaACCESS: A Medicare-Covered Program Built to Improve Blood Pressure, Diabetes, and Heart Health. Under the new CMS ACCESS Model, eligible Original Medicare beneficiaries can receive clinician-guided care and medical-grade connected tools at $0 out-of-pocket cost. Key highlights of KardiaACCESS: 🌐 $0 Cost: Fully covered with no co-pays, no deductibles, and no hidden fees for qualifying Original Medicare (Part B) beneficiaries. 🩺 Comprehensive Focus: Supports the complete Cardio-Kidney-Metabolic (CKM) system as a whole. 📲 Connected Support: Includes connected devices, active clinical progress checks, virtual care visits, lifestyle coaching, and doctor-ready reports. Now live in 48 states. 👇 Explore the program: globenewswire.com/news-relea… #AliveCor #Medicare #DigitalHealth #RemoteMonitoring #HealthEquity #Cardiology

🚀 𝟰𝟬𝟬,𝟬𝟬𝟬,𝟬𝟬𝟬 𝗘𝗖𝗚𝘀 𝗿𝗲𝗰𝗼𝗿𝗱𝗲𝗱. This vast, medical-grade heart data fuels the development of our next-generation AI algorithms, accelerating innovation in cardiac care. As #AFibAwarenessMonth begins, every single one of these recordings represents a step forward in detecting silent heart conditions like Atrial Fibrillation before complications arise. This achievement is a powerful testament to the trust placed in our technology. To our patients, providers, and partners around the world — thank you. Your continued confidence drives us to improve patient outcomes every day. Here’s to impacting millions more lives. 💙 #AFibAwarenessMonth #CardiacCare #HeartHealth #AIinHealthcare #DigitalHealth

Honorary doctorate or not, we’ll take an 8/10 from @MKBHD any day! 🩺⚡ In his new video "I Said Yes to Every Email for a Month! (Again)", Marques took a look at the KardiaMobile 6L Max, highlighting how it puts medical-grade EKG technology right at your fingertips. Huge thanks to Marques and the team for putting KardiaMobile 6L Max to the test. 🎥 Watch the clip here: youtube.com/watch?v=mfmdXPT7… #AliveCor #MKBHD #TechReview #HeartCare #SmartHealth #Cardiology #HealthTech #Kardia

As consumer wellness wearables flood the market, the line between lifestyle tracking and clinical diagnostics is blurring. 📰 In a new op-ed for @medcitynews, AliveCor Founder & Chief Medical Officer @DrDave01 breaks down the FDA’s latest guidance on "general wellness" products—and why distinguishing consumer tech from medical-grade, clinically validated devices is critical for patient safety. "When using general wellness tools, they are consumers. When using medical-grade tools, they’re patients. I want people to know when they become patients." 🔗 Read the full article to see why medical-grade precision matters now more than ever: medcitynews.com/2026/08/the-… #DigitalHealth #MedTech #Cardiology #PatientSafety #AliveCor